Moody Aldrich Partners’s Zymeworks ZYME Stock Holding History

Moody Aldrich Partners’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33,228	Closed	-$1.05M	–	199
2021 Q1	$1.05M	Buy	33,228 +404	+1%	+$16.4K	0.15%	121
2020 Q4	$1.55M	Hold	32,824	–	–	0.25%	100
2020 Q3	$1.53M	Buy	32,824 +787	+2%	+$27K	0.32%	91
2020 Q2	$1.16M	Buy	+32,037	New	+$1.18M	0.25%	101

Other funds holding ZYME

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Moody Aldrich Partners's ZYME Position: Q2 2021 in Review

Moody Aldrich Partners sold out of Zymeworks (ZYME) in Q2 2021, closing a stake of 33,228 shares — an estimated $1.05M sold.

Moody Aldrich Partners first reported a position in ZYME in Q2 2020 and held it in 4 quarters. The position peaked at $1.55M in Q4 2020. 109 funds tracked by Wall St. Rank hold ZYME as of Q2 2021.

Moody Aldrich Partners reported no remaining Zymeworks position as of Q2 2021 after selling out during the quarter.
Moody Aldrich Partners sold 33,228 Zymeworks shares in Q2 2021, an estimated $1.05M.
Moody Aldrich Partners first reported a position in Zymeworks in Q2 2020 and held it in 4 quarters.
Moody Aldrich Partners's Zymeworks position peaked at $1.55M in Q4 2020.
109 funds tracked by Wall St. Rank held Zymeworks as of Q2 2021.

Based on Moody Aldrich Partners's 13F filing for Q2 2021, filed 4 Aug 2021.